Atlas Trials

Escitalopram Effects on CSF Amyloid Beta

Clinical trial NCT02161458 · COMPLETED

Trial details

NCT number
NCT02161458
Sponsor
University of Pennsylvania
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Amyloid Beta Protein
Start date
2014-06-01
Primary completion
2017-08-01
Enrollment
98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.